Cargando…
Dynamic changes and clinical significance of LXA(4) in the perioperative period of cardiopulmonary bypass
Dynamic changes in lipoxin A(4) (LXA(4)) in child patients with congenital heart disease (CHD), in the perioperative period of cardiopulmonary bypass (CPB) were studied. Peripheral blood was collected from 16 child patients (CPB group) before operation (Tc), after operation (T0), at 1 day after oper...
Autores principales: | Wu, Ming, Feng, Zongtai, Liao, Jianyi, Zhou, Huiting, Wang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434242/ https://www.ncbi.nlm.nih.gov/pubmed/30936990 http://dx.doi.org/10.3892/etm.2019.7304 |
Ejemplares similares
-
Aspirin-triggered 15-Epi-Lipoxin A(4) (LXA(4)) and LXA(4) Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors
por: Takano, Tomoko, et al.
Publicado: (1997) -
Cardiopulmonary Bypass Down-Regulates NOD Signaling and Inflammatory Response in Children with Congenital Heart Disease
por: Yang, Qinghua, et al.
Publicado: (2016) -
LXA4 Inhibits Lipopolysaccharide-Induced Inflammatory Cell Accumulation by Resident Macrophages in Mice
por: Mei, Hong-Xia, et al.
Publicado: (2021) -
Perioperative plasma mitochondrial DNA dynamics and correlation with inflammation during infantile cardiopulmonary bypass
por: Xu, Fei, et al.
Publicado: (2017) -
Perioperative considerations in a sickle cell patient undergoing cardiopulmonary bypass
por: Raut, Monish S, et al.
Publicado: (2014)